세부전공

감염질환

질환군

바이러스감염, 세균감염, 열성질환, 뇌수막염, 경부임파선염, 액와임파선염, 서혜부임파선염, 폐렴,기관지염, 장염, 방광염, 신우신염

증상군

고열, 열을 동반한 피부발진, 콧물,기침, 열을 동반한 심한 근육통, 대상포진등의 급성 통증, 열을 동반한 두통과 어지러움,구역,구토, 봉와직염, 근육염, 골수염, 림프절부종 (임파선 비대), 열, 통증, 급성 호흡기계 증상,열,기침,가래, 열을 동반하거나 미열이 있는 급성 설사, 열을 동반한 잔뇨, 빈뇨, 배뇨곤란, 여행전 예방백신접종, 예방약 처방, 국내, 해외 여행전후 진료, 증상상담

송준영 교수의 진료시간표

송준영 교수의 상세정보

• 1992 .03  ~  1998 .02  :  고려대학교 의학과 학사
• 2000 .09  ~  2002 .08  :  고려대학교 내과학(감염학 전공) 석사
• 2002 .09  ~  2007 .08  :  고려대학교 내과학(감염학 전공) 박사

• 2017 .03  ~   :  고려대학교 의과대학 구로병원 감염내과 교수
• 2012 .03  ~  2017 .02  :  고려대학교 의료원 구로병원 감염내과 부교수
• 2009 .03  ~  2012 .02  :  고려대학교 의료원 구로병원 감염내과 조교수
• 2014 .02  ~   :  고려대학교 구로병원 감염관리실장
• 2021 .03  ~   :  Vaccine Innovation Center-KU Medicine (VIC-K) 부센터장
• 2012 .03  ~  2013 .02  :  Visiting scientist, University of Alabama at Birmingham (UAB)

• 2007 .09  :  ASM George McCracken ID Fellow Grant
• 2009 .06  :  ECCMID Travel Grant
• 2020 .01  :  무록남경애 학술대상
• 2022 .12  :  고려대학교 구로병원 학술대상
• 2019 .05  :  석탑연구상
• 2021 .12  :  대통령 표창(감염병관리 유공자)
• 2015 .12  :  보건복지부 장관 표창 (감염병대응 유공자 포상)
• 2011 .12  :  보건복지부 장관 표창(세계 에이즈의 날)

• 2021 .05  ~   :  대한항균요법학회 학술이사
• 2021 .12  ~   :  대한에이즈학회 홍보이사
• 2021 .12  ~   :  대한백신학회 대외협력이사
• 2019 .11  ~  2021 .11  :  대한에이즈학회 학술이사
• 2019 .11  ~  2021 .11  :  대한백신학회 교육이사
• 2019 .11  ~  2021 .11  :  대한감염학회 대외협력이사
• 2017 .12  ~  2019 .11  :  대한감염학회 정책기획이사
• 2015 .12  ~  2017 .11  :  대한감염학회 재무이사
• 2013 .12  ~  2015 .11  :  대한감염학회 총무이사
• 2015 .11  ~  2019 .11  :  대한에이즈학회 기획이사
• 2010 .01  ~  2011 .02  :  대한에이즈학회 간행이사
• 2013 .08  ~  2015 .07  :  대한인수공통전염병학회 학술이사
• 2015 .08  ~  2017 .07  :  대한인수공통전염병학회 총무이사

• 2007 .04  ~   :  한국 HIV/AIDS 코호트 실무위원, 운영위원
• 2014 .08  ~   :  식약처 중앙약사심의위원회 전문위원
• 2014 .05  ~   :  보건복지부 신의료기술평가위원회 분야별 전문평가위원
• 2017 .09  ~  2019 .02  :  질병관리청 예방접종 피해보상 전문위원회 위원
• 2020 .02  ~  2021 .07  :  코로나19 범학회대책위원회 간사
• 2015 .06  ~  2015 .07  :  보건복지부 메르스 즉각대응팀
• 2021 .02  ~   :  질병관리청 예방접종전문위원회 위원
• 2011 .08  ~   :  대한감염학회 성인예방접종위원회 위원
• 2013 .03  ~   :  중소병원 감염관리네트워크(ICCON) 자문위원
• 2018 .03  ~   :  의료중재원 비상임 감정위원
• 2019 .09  ~   :  건강보험심사평가원 비상근 평가위원
• 2013 .09  ~   :  대한백신학회지(Clinical and experimental vaccine research) 부편집인
• 2019 .07  ~   :  대한의료관련감염학회지 부편집인
• 2015 .02  ~   :  대한감염학회 학술지(Infection & Chemotherapy) 간행위원

• 2012 .03  ~  2013 .02  :  Visiting scientist, University of Alabama at Birmingham (UAB)

• [SCI] (COVID-19 Vaccination in Korea: Past, Present, and the Way Forward)
• [SCI] (Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection)
• [SCI] (COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19.)
• [SCI] (Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, phase 1/2 trial)
• [SCI] (The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses.)
• [SCI] (BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality.)
• [SCI] (Duration of humoral immunity and cross-neutralizing activity against the Alpha, Beta, and Delta variants after wild-type SARS-CoV-2 infection.)
• [SCI] (Effectiveness of Pneumococcal Vaccination Against Pneumococcal Pneumonia Hospitalization in Older Adults: A Prospective, Test-Negative Study.)
• [SCI] (Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19.)
• [SCI] (Seroepidemiologic survey of emerging vector-borne infections in South Korean forest/field workers.)
• [SCI] (Covid-19 in South Korea - Challenges of Subclinical Manifestations.)
• [SCI] (Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count)
• [SCI] (Effectiveness of repeated influenza vaccination among the elderly population with high annual vaccine uptake rates during the three consecutive A/H3N2 epidemics.)
• [SCI] (Age-stratified analysis of serotype-specific baseline immunity against group B streptococcus)
• [SCI] (Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults)
• [SCI] (Clinical and microbiological characterization of serotype 6D pneumococcal infections in South Korea)
• [SCI] (Viral shedding from diverse body fluids in a patient with severe fever with thrombocytopenia syndrome)
• [SCI] (Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults)
• [SCI] (Antiviral therapy in seasonal influenza and 2009 H1N1 pandemic influenza: Korean experiences and perspectives)
• [SCI] (Pneumococcal Capsules and Their Types: Past, Present, and Future)
• [SCI] (Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes)
• [SCI] (Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults)
• [SCI] (Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization)
• [SCI] (Epidemiology and clinical features of toxigenic culture-confirmed hospital-onset Clostridium difficile infection: a multicentre prospective study in tertiary hospitals of South Korea)
• [SCI] (Epidemiologic differences of four major respiratory viruses between children, adolescents, and adults in Korea)
• [SCI] (Etiology and clinical outcomes of acute respiratory virus infection in hospitalized adults)
• [SCI] (Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia)
• [SCI] (Pneumococcal vaccine)
• [SCI] (Phase IV: randomized controlled trial to evaluate lot consistency of trivalent split influenza vaccines in healthy adults)
• [SCI] (Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly)
• [SCI] (Transgovernmental Enterprise for Pandemic Influenza in Korea. Severe influenza treatment guideline)
• [SCI] (Age- and influenza activity-stratified case definitions of influenza-like illness: experience from hospital-based influenza surveillance in South Korea)
• [SCI] (Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study)
• [SCI] (Diagnosis of Pneumococcal Pneumonia: Current Pitfalls and the Way Forward)
• [SCI] (Pneumococcal vaccine and opsonic pneumococcal antibody)
• [SCI] (Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence)
• [국외논문] (Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer)
• [국외논문] (Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model)
• [국외논문] (Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis)
• [국외논문] (Clinical outcome and predictive factors of recurrence among patients with Kikuchi's disease)
• [국외논문] (Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii)
• [국외논문] (In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii)
• [국외논문] (Clinical impact of influenza immunization in patients with liver cirrhosis)
• [국외논문] (Disease spectrum of cervical lymphadenitis: analysis based on ultrasound-guided core-needle gun biopsy)

• 감염학
• 성인예방접종 제3판
• 국내유입가능 해외감염병 신규관리지침
• 창상감염

최종수정일 : 2023.03.04